Outdoor Adventure

Header
Download certificate Get Conference photo
Joining code : 9D4214
WCPD
11th World Congress on Prevention of Diabetes and its Complications
30th August - 1st September, 2024
The Westin Mumbai Powai Lake, Mumbai

Abstract

GUIDELINES FOR ABSTRACT SUBMISSION

  • Your abstract title and your abstract must be submitted in English. Your abstract may be automatically rejected if it is submitted in another language.
  • The title of the abstract must be of maximum 200 characters (approximately 30 words).
  • Abstracts, excluding title, authors’ names and affiliations, must be of maximum 2000 characters (approximately 300 words). The main body of the abstract should be structured with the following headings:
  • For original studies: Background, Objectives, Methods, Results, and Conclusions.
  • For case reports: Background, Case Presentation, and Conclusions.
  • Please avoid using abbreviations in the title, if possible. Please reduce to a minimum the use of abbreviations in the main body of the abstract. If you must use an abbreviation, define it upon first use.
  • Figures and tables should not be included in your abstract.
  • References can be included in your abstract but will be included in your word count.
  • You must not include your abstract title or author names in the abstract document.
  • Please ensure that you add all the authors of your abstract onto the submission form, including yourself if you are an author.
  • Please ensure correct spelling and affiliations are used. We are unable to add or amend author names once abstracts have been published.
  • You must provide a valid email address for your listed presenting author. This will be used to contact the presenter regarding uploading presentations or posters, if your submission is successful. Please note that by providing an email address, you are confirming that you have the author’s consent to share their contact details.
  • Last date of Abstract Submission is 31st July, 2024.
SUBMIT YOUR ABSTRACT

Thanks for the overwhelming response!

Abstract submission is now closed.

The list of shortlisted abstracts will be updated on www.WCPD-DRS.com by August 15th, 2024.

E-Poster : 31ST aUGUST, 2024 - 02:30pm - 04:30pm

Responsive Table
Time Topic Name
02:30PM - 02:36PM Ezetimibe as Add on Therapy with Statins in Diabetic Dyslipidemia Soumyaranjan Mohanty
02:36PM - 02:42PM Prevalence and Risk Factors of Development of Peripheral Diabetic Neuropathy in Type 2 Diabetes Mellitus Vaibhav Survase
02:42PM - 02:48PM Burdens of Diabetes and Hyperglycemia in Adults Aastha Naik
02:48PM - 02:54PM Prevalence of Diabetic Retinopathy Arjun Khadse
02:54PM - 03:00PM Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors Juhi Ramnani
03:00PM - 03:06PM Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes According to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use—ONWARDS 1–5 Usha Rani Patted
03:06PM - 03:12PM The Clinical & Investigational Profile of Peripheral Neuropathy in Diabetic Patients Attending a Tertiary Care Centre Nithish Reddy
03:12PM - 03:18PM Association of HbA1c with Vibrating Perception Threshold in Patients with Type 2 Diabetes Mellitus Shruti Gangwani
03:18PM - 03:24PM Non-Invasive Liver Stiffness Measurement in an Out-Patient Department using Fibroscan Technology Ritu Johari
03:24PM - 03:30PM Complex of Hybrid Diabetes Mellitus with Severe Insulin Resistance and Cerebrovascular Complications- A case report Pranjali Shah
03:30PM - 03:36PM Cardiovascular Risk in Type 2 Diabetes Patients Discussion
03:36PM - 03:42PM Experience with New Age Medicines in Diabetes: SGLT2-Inhibitors and DPP4-Inhibitors in Indian Patients Lotika Purohit
03:42PM - 03:48PM Glycemic Variability and Its Determinants: A Case Report of a 59-Year-Old Woman with Type 2 Diabetes and Its Implications for Diabetes Management Araina Trehon
03:48PM - 03:54PM Age-wise Distribution of Clinical and Demographic Characteristics Among Indian Patients with Hypertension Receiving Telmisartan and Amlodipine Fixed-dose Combination Preethi Naik
03:54PM - 04:00PM Real World Evidence Based Presentation of Diabetic Induced Asymptomatic Leukocytosis Indian Origin Sunil Kamble
04:00PM - 04:06PM Impact of Dinner Timings on Fasting Glucose Levels in Patients with Type 2 Diabetes Mellitus Aniket Inamdar
04:06PM - 04:12PM Association of Fasting Plasma Glucose Levels with Wake-up Timings in Diabetic Patients in India Aniket Inamdar